Blinatumomab

(Mfr: AMG)(Conc: 0.375 mcg/mL^b)

Teicoplanin

(Mfr: SAA)(Conc: 4 mg/mL^a)

Remarks:

Persistent particulate formation when blinatumomab is added to teicoplanin; not observed when order of mixing was reversed

Ref:

³⁴⁰⁵,³⁴¹⁷